U.S. flag

An official website of the United States government

NM_002691.4(POLD1):c.1687-1G>A AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 2, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000562574.3

Allele description [Variation Report for NM_002691.4(POLD1):c.1687-1G>A]

NM_002691.4(POLD1):c.1687-1G>A

Gene:
POLD1:DNA polymerase delta 1, catalytic subunit [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.33
Genomic location:
Preferred name:
NM_002691.4(POLD1):c.1687-1G>A
HGVS:
  • NC_000019.10:g.50407326G>A
  • NG_033800.1:g.28004G>A
  • NM_001256849.1:c.1687-1G>A
  • NM_001308632.1:c.1687-1G>A
  • NM_002691.4:c.1687-1G>AMANE SELECT
  • LRG_785t1:c.1687-1G>A
  • LRG_785t2:c.1687-1G>A
  • LRG_785:g.28004G>A
  • NC_000019.9:g.50910583G>A
  • NM_002691.2:c.1687-1G>A
Links:
dbSNP: rs1555791492
NCBI 1000 Genomes Browser:
rs1555791492
Molecular consequence:
  • NM_001256849.1:c.1687-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001308632.1:c.1687-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_002691.4:c.1687-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000671160Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)		Uncertain significance
(Jan 2, 2019) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV000671160.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.1687-1G>A intronic variant results from a G to A substitution one nucleotide upstream from coding exon 13 of the POLD1 gene. This nucleotide position is highly conserved in available vertebrate species. Using two different splice site prediction tools, this alteration is predicted to abolish the native splice acceptor site and to significantly weaken (but not abolish) the efficiency of the native splice acceptor site by BDGP and ESEfinder, respectively; however, direct evidence is unavailable. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. However, loss of function via haploinsufficiency in POLD1 has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024